Antisense Oligonucleotides Directed Against a Human Endogenous Retrovirus for Treatment of Amyotrophic Lateral Sclerosis
Saved in:
| Main Authors: | Kevon Sampson, M.S., Wenxue Li, Ph.D., Myoung Hwa Lee, Ph.D., Lisa Henderson, Ph.D., Avindra Nath, M.D. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-07-01
|
| Series: | Neurotherapeutics |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924000850 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
by: Daisuke Ito, et al.
Published: (2024-12-01) -
HERV-K/HML-2 Suppression Using Antiretroviral Therapy in Amyotrophic Lateral Sclerosis (ALS)
by: Darshan Pandya, M.D., et al.
Published: (2025-07-01) -
Development of an Fc-fusion HERV-K vaccine to treat amyotrophic lateral sclerosis and frontotemporal dementia
by: Marta Garcia-Montojo, Ph.D.
Published: (2025-07-01) -
Characterization of novel human endogenous retrovirus structures on chromosomes 6 and 7
by: Nicholas Pasternack, et al.
Published: (2025-01-01) -
Beyond the Eye: AI-Enhanced Visual Biomarker Discovery and Tracking for Amyotrophic Lateral Sclerosis Preliminary Data
by: Terry Heiman-Patterson, M.D., et al.
Published: (2025-07-01)